Beppino C. Giovanella, Ph.D.
Zhisong Cao, Ph.D.
Associate Laboratory Director, Chief Chemist
Deputy Director/Clinical Operations Officer
Constantine Markides, Ph.D.
Xing (Lucy) Liu, Ph.D.
Research Scientist, Analytical Chemistry
Anthony (Tony) Kozielski
Section Supervisor, Chemotherapy
Yang Wang, Ph.D.
Research Scientist, Synthetic Chemistry
Tissue Culture Supervisor
Edward (Eddie) Petry, Jr.
Vivarium Section Supervisor
CHRISTUS Stehlin Foundation for Cancer Research will join CHRISTUS St. Catherine and CHRISTUS St. John in a new partnership with Houston Methodist.
There are currently 13.7 million cancer survivors in the United States and the number is expected to rise by 31 percent to 18 million by 2022, according to a new report. >> Click article title for more.
“Dr. Stehlin has been right about cancer for more than 40 years . . . He achieved his remarkable success by carefully observing the behavior of cancer. He found order where others had only seen chaos. He found rules where others said there were no rules. And he spared hundreds of patients the disfiguring consequences of radical surgery.”
Dr. Richard Evans,
General Surgeon, 2007